Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid Injection vs Open Surgical Release for De Quervain Tenosynovitis
NCT07683429Completed
- Sponsor
- Rawalpindi Teaching Hospital
- Start
- Mar 2023
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
Open-label trial of triamcinolone acetonide in De Quervain's tenosynovitis (DQT) (2 arms), sponsored by Rawalpindi Teaching Hospital. Primary endpoint: Visual Analog Scale at 6 months. Started Mar 2023; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
De Quervain's tenosynovitis (DQT)
Beyond the preview
Go deeper on NCT07683429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07683429.